• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在聚丙烯瓶和袋中,将羧基麦芽糖铁稀释于氯化钠输液溶液(0.9% w/v)中:对化学稳定性的影响。

Diluting ferric carboxymaltose in sodium chloride infusion solution (0.9% w/v) in polypropylene bottles and bags: effects on chemical stability.

作者信息

Philipp Erik, Braitsch Michaela, Bichsel Tobias, Mühlebach Stefan

机构信息

Vifor (International) AG , St. Gallen , Switzerland.

Laboratorium Dr. G. Bichsel AG , Unterseen , Switzerland.

出版信息

Eur J Hosp Pharm. 2016 Jan;23(1):22-27. doi: 10.1136/ejhpharm-2015-000697. Epub 2015 Aug 12.

DOI:10.1136/ejhpharm-2015-000697
PMID:26835007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4717364/
Abstract

OBJECTIVES

This study was designed to assess the physicochemical stability of colloidal ferric carboxymaltose solution (Ferinject) when diluted and stored in polypropylene (PP) bottles and bags for infusion.

METHODS

Two batches of ferric carboxymaltose solution (Ferinject) were diluted (500 mg, 200 mg and 100 mg iron in 100 mL saline) in PP bottles or bags under aseptic conditions. The diluted solutions were stored at 30°C and 75%±5% relative humidity (rH) for 72 h, and samples were withdrawn aseptically at preparation and after 24 h, 48 h and 72 h. Multiple parameters were used to test stability-related measures (pH, total iron and iron (II) content, molecular weight range determination, microbial contamination and particles count ≥10 μm).

RESULTS

Overall, Ferinject diluted in 0.9% (w/v) NaCl solution and stored in PP bottles and bags was stable within the specifications for the complex and the acceptability limits set for all assays. In both containers, total iron content remained stable, within 10% of the theoretical iron content, and levels of iron (II) remained far below the threshold of acceptability. All preparations were free from sediments, particle numbers were acceptable and there was no microbial contamination. The molecular weight distribution and polydispersity index were also acceptable.

CONCLUSIONS

Under the tested experimental conditions, colloidal ferric carboxymaltose solution (Ferinject) diluted in saline in PP infusion bottles or bags demonstrated physical and chemical stability for up to 72 h at 30°C and 75% rH. Because of the lack of additional clinical data, when using ferric carboxymaltose, physicians/pharmacists should refer to the dilution and storing recommendations given in the product's summary of product characteristics.

摘要

目的

本研究旨在评估胶体羧麦芽糖铁溶液(费乐必注)在稀释后储存在聚丙烯(PP)输液瓶和输液袋中的理化稳定性。

方法

两批羧麦芽糖铁溶液(费乐必注)在无菌条件下于PP瓶或袋中稀释(分别为100 mL盐水中含500 mg、200 mg和100 mg铁)。稀释后的溶液在30°C和相对湿度75%±5%(rH)下储存72小时,在配制时以及24小时、48小时和72小时后无菌抽取样品。使用多个参数来测试与稳定性相关的指标(pH值、总铁和亚铁含量、分子量范围测定、微生物污染以及粒径≥10μm的颗粒计数)。

结果

总体而言,在0.9%(w/v)氯化钠溶液中稀释并储存在PP瓶和袋中的费乐必注在复合物的规格以及所有检测设定的可接受限度内是稳定的。在两个容器中,总铁含量保持稳定,在理论铁含量的10%以内,亚铁水平仍远低于可接受阈值。所有制剂均无沉淀,颗粒数量可接受,且无微生物污染。分子量分布和多分散指数也可接受。

结论

在测试的实验条件下,在PP输液瓶或袋中用盐水稀释的胶体羧麦芽糖铁溶液(费乐必注)在30°C和75% rH下理化稳定性可达72小时。由于缺乏额外的临床数据,使用羧麦芽糖铁时,医生/药剂师应参考产品特性摘要中给出的稀释和储存建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9284/6451625/c1de1e68abee/ejhpharm-2015-000697f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9284/6451625/d7bbf5cf5673/ejhpharm-2015-000697f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9284/6451625/c1de1e68abee/ejhpharm-2015-000697f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9284/6451625/d7bbf5cf5673/ejhpharm-2015-000697f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9284/6451625/c1de1e68abee/ejhpharm-2015-000697f01.jpg

相似文献

1
Diluting ferric carboxymaltose in sodium chloride infusion solution (0.9% w/v) in polypropylene bottles and bags: effects on chemical stability.在聚丙烯瓶和袋中,将羧基麦芽糖铁稀释于氯化钠输液溶液(0.9% w/v)中:对化学稳定性的影响。
Eur J Hosp Pharm. 2016 Jan;23(1):22-27. doi: 10.1136/ejhpharm-2015-000697. Epub 2015 Aug 12.
2
In-Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period.在延长储存期后,SB12(依库珠单抗,苏立生生物类似药)在生理盐水和葡萄糖输液中的使用稳定性。
Drugs R D. 2023 Dec;23(4):363-375. doi: 10.1007/s40268-023-00433-7. Epub 2023 Aug 22.
3
Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags.复溶后的赫赛汀在商用静脉输液袋中的长期使用稳定性
Int J Pharm Compd. 2018 Sep-Oct;22(5):417-423.
4
An Optimized Process for the Preparation of Aqueous Ferric Carboxymaltose: Synthesis and Structural Characterization.优化的羧甲麦芽糖铁水溶液的制备工艺:合成与结构表征。
Pharm Nanotechnol. 2021;9(2):157-163. doi: 10.2174/2211738509666210114160941.
5
Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes.磷苯妥英钠在玻璃瓶、聚氯乙烯袋和聚丙烯注射器中的静脉输液稳定性。
Ann Pharmacother. 1997 May;31(5):553-9. doi: 10.1177/106002809703100505.
6
Short-term stability of a new generic sodium ferric gluconate in complex with sucrose.新型蔗糖结合的葡甲胺铁的短期稳定性。
Curr Med Res Opin. 2011 Dec;27(12):2241-3. doi: 10.1185/03007995.2011.628304. Epub 2011 Oct 12.
7
Stability of cyclosporine solutions stored in polypropylene-polyolefin bags and polypropylene syringes.环孢素溶液在聚丙烯-聚烯烃袋和聚丙烯注射器中的稳定性。
Am J Health Syst Pharm. 2011 Sep 1;68(17):1646-50. doi: 10.2146/ajhp100445.
8
Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags.奥沙利铂在聚氯乙烯、聚乙烯和聚丙烯输液袋中 5%葡萄糖注射液中的物理化学稳定性。
Am J Health Syst Pharm. 2009 Nov 1;66(21):1929-33. doi: 10.2146/ajhp090039.
9
Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers.青霉素G钠用0.9%氯化钠注射液或5%葡萄糖注射液稀释后,储存在聚氯乙烯袋容器和弹性泵容器中的稳定性。
Am J Health Syst Pharm. 2014 Apr 15;71(8):669-73. doi: 10.2146/ajhp130440.
10
Drug compatibility with various closed intravenous infusion containers.药物与各种密闭静脉输液容器的相容性。
Front Pharmacol. 2024 Jan 8;14:1265945. doi: 10.3389/fphar.2023.1265945. eCollection 2023.

引用本文的文献

1
Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics.静脉铁-碳水化合物纳米复合物表面特性的关键性:对药代动力学和药效学的影响。
Int J Mol Sci. 2022 Feb 15;23(4):2140. doi: 10.3390/ijms23042140.

本文引用的文献

1
The role of iron in the skin and cutaneous wound healing.铁在皮肤及皮肤伤口愈合中的作用。
Front Pharmacol. 2014 Jul 10;5:156. doi: 10.3389/fphar.2014.00156. eCollection 2014.
2
Nanomedicines: addressing the scientific and regulatory gap.纳米药物:解决科学和监管差距。
Ann N Y Acad Sci. 2014 Apr;1313:35-56. doi: 10.1111/nyas.12403. Epub 2014 Mar 27.
3
A systematic analysis of global anemia burden from 1990 to 2010.1990 年至 2010 年全球贫血负担的系统分析。
Blood. 2014 Jan 30;123(5):615-24. doi: 10.1182/blood-2013-06-508325. Epub 2013 Dec 2.
4
How to regulate nonbiological complex drugs (NBCD) and their follow-on versions: points to consider.如何监管非生物复杂药物(NBCD)及其后续版本:需考虑的要点。
AAPS J. 2014 Jan;16(1):15-21. doi: 10.1208/s12248-013-9533-z. Epub 2013 Sep 25.
5
Different pharmaceutical products need similar terminology.不同的药品需要类似的术语。
AAPS J. 2014 Jan;16(1):11-4. doi: 10.1208/s12248-013-9532-0. Epub 2013 Sep 25.
6
Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines.下一代纳米药物和纳米类似物:欧盟监管机构在纳米药物研发和评估方面的举措。
Nanomedicine (Lond). 2013 May;8(5):849-56. doi: 10.2217/nnm.13.68.
7
Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients.静脉注射蔗糖铁和类似蔗糖铁在产后和妇科手术患者中的不良事件谱比较。
Curr Med Res Opin. 2013 Feb;29(2):141-7. doi: 10.1185/03007995.2012.760444. Epub 2013 Jan 8.
8
Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives.缺铁与心力衰竭:诊断难题与治疗策略。
Eur Heart J. 2013 Mar;34(11):816-29. doi: 10.1093/eurheartj/ehs224. Epub 2012 Oct 25.
9
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study.静脉注射羧甲麦芽糖铁对慢性心力衰竭伴缺铁患者健康相关生活质量的影响:FAIR-HF 研究的亚分析。
Eur Heart J. 2013 Jan;34(1):30-8. doi: 10.1093/eurheartj/ehr504. Epub 2012 Jan 31.
10
FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.FERGIcor 研究:一项评估羧基麦芽糖铁治疗炎症性肠病缺铁性贫血的随机对照试验
Gastroenterology. 2011 Sep;141(3):846-853.e1-2. doi: 10.1053/j.gastro.2011.06.005. Epub 2011 Jun 12.